...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: AGM - Jan 7, 2016 - Details
10
Jan 08, 2016 10:43AM

Thanks Masila. You rock! My favorite part:

"Q: Future of ZCC, especially what will be done with revenue streams?

A: Dividends, Dividends, Dividends. We aren’t contemplating any further investments. We already have ZEL and RVX. There’s 20 years of development effort at those two alone. We have our hands full."

BearDownAZ

7
Jan 12, 2016 07:15PM
1
Jan 12, 2016 10:50PM
3
Jan 13, 2016 05:08PM
1
Jan 14, 2016 10:03AM
3
Jan 14, 2016 10:25AM
1
Jan 14, 2016 11:25AM
4
Jan 14, 2016 03:17PM
5
Jan 15, 2016 01:08AM
3
Jan 15, 2016 09:24AM
Share
New Message
Please login to post a reply